(Q33521047)

27 July 2017

CD14-independent responses induced by a synthetic lipid A mimetic (English)

1 reference

27 July 2017

Amandine Legat

1

1 reference

27 July 2017

Séverine Thomas

2

1 reference

27 July 2017

Philippe Hermand

3

1 reference

27 July 2017

Marcelle Van Mechelen

4

1 reference

27 July 2017

Michel Goldman

5

1 reference

27 July 2017

Dominique De Wit

6

1 reference

27 July 2017

language of work or name

English

0 references

publication date

1 March 2010

1 reference

European Journal of Immunology

27 July 2017

1 reference

27 July 2017

40

1 reference

27 July 2017

3

1 reference

27 July 2017

797-802

1 reference

TLR4 agonists as immunomodulatory agents.

27 July 2017

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939992

Administration of a synthetic TLR4 agonist protects mice from pneumonic tularemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939992

Immunostimulatory activity of aminoalkyl glucosaminide 4-phosphates (AGPs): induction of protective innate immune responses by RC-524 and RC-529.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939992

Soluble CD14 discriminates slight structural differences between lipid as that lead to distinct host cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939992

Synthetic TLR4-active glycolipids as vaccine adjuvants and stand-alone immunotherapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939992

7 January 2021

Structure-activity relationship of synthetic toll-like receptor 4 agonists

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939992

7 January 2021

Endotoxin recognition and signal transduction by the TLR4/MD2-complex

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939992

7 January 2021

Innate recognition of lipopolysaccharide by Toll-like receptor 4-MD-2.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939992

7 January 2021

CD14 is required for MyD88-independent LPS signaling.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939992

7 January 2021

Lipopolysaccharide signaling in endothelial cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939992

7 January 2021

Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939992

7 January 2021

Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939992

7 January 2021

Impaired phagocyte responses to lipopolysaccharide in paroxysmal nocturnal hemoglobinuria

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939992

7 January 2021

Enhancement of antigen-specific immunity via the TLR4 ligands MPL adjuvant and Ribi.529.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939992

7 January 2021

New horizons in adjuvants for vaccine development

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939992

7 January 2021

Identifiers

DOI

10.1002/EJI.200939992

1 reference

27 July 2017

1 reference